A PROSPECTIVE RANDOMIZED STUDY OF IMATINIB 400 MG VS 800 MG AS A FRONTLINE THERAPY IN SOKAL HIGH RISK (HR) PH-POS CHRONIC MYELOID LEUKEMIA (CML) PATIENTS

被引：69

作者：

Baccarani, M. ^{[1
]}

Haznedaroglu, I. ^{[2
]}

Porkka, K. ^{[3
]}

Castagnetti, F. ^{[1
]}

Alberti, D. ^{[4
]}

Alimena, G. ^{[5
]}

Amabile, M. ^{[1
]}

Bostrom, H. ^{[6
]}

Hjorth-Hansen, H. ^{[7
]}

Kairisto, V. ^{[6
]}

Martinelli, G. ^{[1
]}

Nielsen, J. ^{[8
]}

Palandri, F. ^{[1
]}

Pane, F. ^{[9
]}

Rege-Cambrin, G. ^{[10
]}

Russo, D. ^{[11
]}

Saglio, G. ^{[10
]}

Specchia, G. ^{[12
]}

Testoni, N. ^{[1
]}

Weiss-Bjerrum, O. ^{[13
]}

Rosti, G. ^{[1
]}

Simonsson, B. ^{[14
]}

机构：

[1] Dpt Hematol Oncol Seragnoli, Bologna, Italy

[2] Ankara Univ, Hematol Unit, TR-06100 Ankara, Turkey

[3] Univ Helsinki, Cent Hosp, Hematol Res Unit, Helsinki, Finland

[4] Novartis Oncol Italy, Origgio, VA, Italy

[5] Univ Roma La Sapienza, Hematol Unit, Rome, Italy

[6] Univ Uppsala Hosp, Dpt Clin Genet, Uppsala, Sweden

[7] Univ Trondheim, Hematol Unit, Trondheim, Norway

[8] Aarhus Univ, Hematol Unit, Aarhus, Denmark

[9] Univ Naples Federico II, Oncohematol Unit, Naples, Italy

[10] Univ Turin, Dpt Clin & Biol Sci, Turin, Italy

[11] Univ Brescia, Hematol Unit, Brescia, Italy

[12] Univ Bari, Hematol Unit, Bari, Italy

[13] Univ Hosp, Dpt Hematol, Copenhagen, Denmark

[14] Uppsala Univ, Hematol Unit, Uppsala, Sweden

来源：

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2008年 / 93卷

关键词：

D O I：

10.3324/haematol.12588

中图分类号：

R5 [内科学];

学科分类号：

1002 [临床医学]; 100201 [内科学];

摘要：

0405

引用

页码：161 / 162

页数：2